About pcm

Manuscript Submission

AME Editing Service

Reprint & Permission

Advertising

Contact us

Case Report 
Efficacy of pembrolizumab in lung adenocarcinoma harboring non-V600E BRAF mutation: a case report
Giuseppina-Rita Di Fazio, Fabrizio Citarella, Emanuela Dell’Aquila, Marco Russano, Alessandro Galletti, Valentina Santo, Bruno Vincenzi, Giuseppe Tonini, Daniele Santini
Precision Cancer Medicine  
2022;
5:
10  
Case Report 
Uncommon EGFR mutations: state-of-the-art and case reports
Francesca Simionato, Lorenzo Calvetti
Precision Cancer Medicine  
2022;
5:
9  
Case Report 
ALK non-small cell lung cancer sequence of treatment: a case report
Alonso García Miriam, Sánchez Gastaldo Amparo, Bernabé Caro Reyes, Benedetti Pedroza Johana Cristina, Carrasco García Irene
Precision Cancer Medicine  
2022;
5:
8  
Case Report 
Primary lung secretory carcinoma: a case report
Huihua Li, Darya Buehler, Jefree J. Schulte
Precision Cancer Medicine  
2022;
5:
7  
Review Article 
New driver alterations in non-small cell lung cancer: a narrative review
Marco Filetti, Alessandro Rossi, Beatrice Taurelli Salimbeni, Marta Piras, Evelina Rogges, Arianna Di Napoli, Paolo Marchetti, Raffaele Giusti
Precision Cancer Medicine  
2022;
5:
5  
Review Article 
Mechanisms of resistance after crizotinib or second-generation ALK therapy in advanced non-small cell lung cancer
Jordi Remon, Laura Esteller, Lizza E. L. Hendriks
Precision Cancer Medicine  
2022;
5:
4  
Review Article 
Role of radiation therapy in triple negative breast cancer: current state and future directions—a narrative review
Fares Azoury, Shagun Misra, Aisling Barry, Joelle Helou
Precision Cancer Medicine  
2022;
5:
3  
Original Article 
Outcomes of head and neck angiosarcoma with different treatment modalities: a 20-year single institutional experience
Yen Sin Koh, Jason Yongsheng Chan, Wen Shen Looi, Mohamad Farid, N Gopalakrishna Iyer, Ci-An Gerald Tay, Kiattisa Sommat, Ru Xin Wong
Precision Cancer Medicine  
2022;
5:
2  
Editorial 
ALK and ROS-1 NSCLC patients treatment approach based on genomic profile by liquid biopsy
Ernest Nadal, Laura Mezquita, Jesús Corral
Precision Cancer Medicine  
2022;
5:
1  
Case Report 
Partial hippocampal sparing whole brain radiotherapy in a patient with bilateral malignant melanoma metastases to the hippocampus: a case report
Michael J. McKay, Hassan Shoushtari Zadeh, Carolyn Sanderson, Thomas A. McKay, Aaron Chindewere
Precision Cancer Medicine  
2021;
4:
39  
Review Article 
A narrative review of genetic factors affecting fluoropyrimidine toxicity
William H. Gmeiner
Precision Cancer Medicine  
2021;
4:
38  
Review Article 
Empowering childhood cancer survivors through integrated, individualized health insurance education
Brittany C. Kimball, Matthew R. Kudek, Daniel Van Ly, Sarah Eagle, Vanessa Hausman, Eleanor Plaunt, Hee Yun Lee, Karim Thomas Sadak
Precision Cancer Medicine  
2021;
4:
37  
Review Article 
Wielding a double-edged sword in head and neck cancers—diagnosis, risk factors and mitigation strategies of radiation-induced head and neck sarcomas: a narrative review
Tabitha Y. Chan, Venkatesh Alagappan, Balamurugan Vellayappan
Precision Cancer Medicine  
2021;
4:
36  
Review Article 
Metabolic reprogramming and cancer precision medicine: a narrative review
Hong Zhang, Shuang Tang
Precision Cancer Medicine  
2021;
4:
35  
Review Article 
Precision cancer medicine in China: the Fudan University Shanghai Cancer Center experience
Lei-Jie Dai, Ding Ma, Zhi-Ming Shao
Precision Cancer Medicine  
2021;
4:
34  
Review Article 
A narrative review of microRNA therapeutics: understanding the future of microRNA research
Linhui Liang, Xianghuo He
Precision Cancer Medicine  
2021;
4:
33  
Review Article 
FDA-led consortium studies advance quality control of targeted next generation sequencing assays for precision oncology
Dan Li, Rebecca Kusko, Baitang Ning, Weida Tong, Donald J. Johann Jr, Joshua Xu
Precision Cancer Medicine  
2021;
4:
32  
Original Article 
Comparison of cancer incidence and mortality between China and the United States
Zezhou Wang, Changming Zhou, Xiaoshuang Feng, Miao Mo, Jie Shen, Ying Zheng
Precision Cancer Medicine  
2021;
4:
31  

Case Report


Editorial

AR-V7 and treatment selection in advanced prostate cancer: are we there yet?
Diogo A. Bastos, Emmanuel S. Antonarakis

Case Report: Precision Oncology Tumor Board

Cases of ROS1-rearranged lung cancer: when to use crizotinib, entrectinib, lorlatinib, and beyond?
Kartik Sehgal, Andrew J. Piper-Vallillo, Hollis Viray, Adeel M. Khan, Deepa Rangachari, Daniel B. Costa